文献速递中枢神经肿瘤放疗姑息放疗与转移瘤

脑转移瘤立体定向放射外科后复发的手术切除术后管理及辅助放疗获益预测

Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation.
PubMed 文献 · Pract Radiat Oncol · 2023-06-08

本研究回顾性分析了2009至2017年间225例脑转移瘤接受立体定向放射外科(SRS)后行手术切除的患者,其中65%为术后影像全切除(GTR),21例(9.3%)接受术腔辅助放疗,204例(90.7%)观察。中位随访13个月,47例(40%)出现局部失败;在GTR且病理有肿瘤证据的118例中局部失败率为40%。作者认为该失败率足够高,建议在此类病例中考虑辅助放疗。

要点

  • SRS后复发脑转移行 salvage 切除后局部失败率较高,GTR且病理有肿瘤者达40%。
  • 仅9.3%患者接受术腔辅助放疗,绝大多数观察。
  • 作者建议病理有肿瘤者即使GTR也应考虑辅助放疗。

核心结论

  • SRS后复发脑转移 salvage 切除后,GTR且病理有肿瘤证据者局部失败率为40%,作者认为该失败率足够高,建议此类病例考虑术腔辅助放疗。

研究设计与样本

  • 回顾性研究,纳入2009至2017年因脑转移接受SRS后对同一病灶行手术切除的225例患者。

主要发现

  • 225例中65%术后影像复查为GTR,21例(9.3%)接受术腔辅助放疗,204例(90.7%)观察。
  • 204例观察患者中118例为GTR且病理标本可见肿瘤。
  • 切除术后中位随访13个月,47例(40%)出现局部失败。
  • GTR且病理有肿瘤证据者局部失败率为40%。

关键数值与推荐

  • GTR且病理有肿瘤证据者局部失败率40%。

临床怎么用

  • 作者建议SRS后 salvage 切除术后,若病理有肿瘤,即使GTR也应考虑术腔辅助放疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Stereotactic radiosurgery (SRS) is often used as upfront treatment for brain metastases. Progression or radionecrosis after SRS is common and can prompt resection. However, postoperative management strategies after resection for SRS failure vary widely, and no standard practice has been established. In this approved study, we retrospectively reviewed patients who received SRS for a brain metastasis followed by resection of the same lesion. We extracted patient-, disease-, and treatment-related variables and information on disease-related outcomes. Univariate and multivariate analyses of clinicopathologic variables were used to create a model to predict factors associated with local failure (LF). A total of 225 patients with brain metastases treated with SRS from 2009 to 2017 followed by surgical resection were identified. Overall, 65% of cases had gross total resection (GTR) on postoperative imaging review. Twenty-one patients (9.3%) received adjuvant radiation therapy to the surgical cavity, and 204 (90.7%) were observed. Of these 204 patients, 118 had GTR with evidence of tumor within the pathology specimen. With a median follow-up of 13 months after resection, 47 patients (40%) developed LF after surgery. After salvage resection of a brain metastasis initially treated with SRS, the observed LF rate was 40% among those who had a GTR and evidence of tumor on pathologic examination. This LF rate is sufficiently high that adjuvant radiation to the surgical bed after salvage resection should be considered in these cases when there is tumor in the pathology, even after a GTR.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Buszek SM, Tran B, Long JP, et al. Postoperative Management of Recurrence After Radiosurgery and Surgical Resection for Brain Metastases and Predicting Benefit From Adjuvant Radiation. Pract Radiat Oncol. 2023. PMID: 37295724. doi:10.1016/j.prro.2023.05.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。